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aim: Acinetobacter bereziniae clinical relevance is starting to be recognized; however, very 
few descriptions of its carbapenem resistance currently exist. Here we characterize two 
carbapenem-resistant A. bereziniae isolates. materials & methods: Isolates were obtained 
from environmental and clinical samples. Carbapenemases were searched by phenotypic, 
biochemical and PCR assays. Clonality was studied by ApaI-PFGE and genetic location for 
carbapenemase genes were assessed by I-CeuI and S1 hybridizations. results: Isolates 
were not clonally related but both produced the ‘exclusively Portuguese’ IMP-5, with the 
clinical isolate also producing an OXA-58. The carbapenemase genes were plasmid located. 
Conclusion: Our results emphasize the role of non-baumannii Acinetobacter species as 
important reservoirs of clinically relevant resistance genes that could also contribute to their 
emergence as nosocomial pathogens.
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Metallo-β-lactamases (MBLs) currently represent an important and emerging mechanism of 
acquired-carbapenem resistance in Gram-negative bacteria, responsible for difficult-to-treat noso-
comial infections, and are consequently associated with both high morbidity and mortality rates. 
Enzymes belonging to VIM and IMP families are among the most prevailing MBLs, rapidly grow-
ing and conferring the greatest clinical threat. Thus far, the IMP-5 MBL has only been described 
in Portugal, initially in an Acinetobacter baumannii clinical isolate belonging to the sequence type 
(ST) 120 and posteriorly in Pseudomonas aeruginosa clinical isolates [1–3]. The bla
IMP-5
 gene was 
described as part of the class 1 integron In76, located on a Tn402-like transposon, with two min-
iature inverted-repeat transposable elements (MITE)-like flanking the 5′CS to 3′CS regions [1,2]. 
This structure, also associated with other resistance determinants, such as bla
PER-1
 in Acinetobacter 
johnsonii, represents a mobilizable unit which might be responsible for intra- and interspecies 
transfer, via transposition or homologous recombination [2,3]. Notwithstanding, the reservoir of 
the ‘exclusively Portuguese’ bla
IMP-5
 gene is yet to be known.
Within the last decades, Acinetobacter species have, surprisingly and successively, evolved from 
traditionally harmless organisms into important nosocomial pathogens exhibiting high levels of 
antibiotic resistance, including extreme drug resistance [4,5]. Acinetobacter bereziniae (formerly 
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Acinetobacter genomospecies 10) is presently con-
sidered one of the non-baumannii Acinetobacter 
emerging pathogenic species [6]. Descriptions of 
this species include vegetable samples [7], fecal 
carriage among healthy humans [8] and different 
human clinical specimens, suggesting its wide 
distribution [9]. More recently, it has also been 
associated with chronic obstructive pulmonary 
disease, urinary tract infection, pneumonia, sep-
sis and bacteremia [6,10–11]. Reports on carbap-
enem resistance in A. bereziniae were previously 
associated with the production of IMP-1 and 
IMP-19, SIM-1, VIM-2 and NDM-1 MBLs [10–
13]. Additionally, two variants of the intrinsic 
oxacillinase OXA-228-like, OXA-229 and 
OXA-257, able to confer carbapenem resistance 
when overexpressed, were recently described in 
A. bereziniae [14,15].
This report aims the characterization of two 
A. bereziniae isolates obtained in the same hos-
pital, from the water of a newborn incubator’s 
humidity chamber and from a blood culture, 
which exhibited an unusual multidrug resistance 
phenotype, including resistance to carbapenems.
materials & methods
Two A. bereziniae isolates, obtained at an inter-
val of 4 years in the same University Hospital in 
Portugal, were studied. Acinetobacter bereziniae 
HGSA93 was collected in 2008 from the water 
reservoir of a new-born’s incubator humidity sys-
tem, while A. bereziniae HGSA593 was obtained 
in 2012 from a blood culture of a hospitalized 
patient with chronic renal disease. Isolates 
were initially identified as Acinetobacter lwoffii 
by the vitek 2 system. Further identification 
included rpoB gene partial sequencing [16] and 
PCR searching for Acinetobacter species-specific 
oxacillinase, OXA-228-like, using previously 
described primers [14].
Antibiotic susceptibility testing was per-
formed by disc diffusion method and E-test 
following CLSI guidelines [17]. Carbapenemase 
production was assessed by the Blue-Carba 
test [18]. Furthermore, isolate crude extracts were 
used to conduct a bioassay with imipenem (with 
and without EDTA).
Acquired carbapenemase genes (MBL and 
carbapenem-hydrolyzing class D β-lactamases 
[CHDL]) were searched by PCR using prim-
ers and conditions as previously described [1,19], 
and confirmed by sequencing. Class 1 inte-
grons were searched with primers directed for 
5′CS and 3′CS regions [20] and confirmed by 
sequencing. Additionally, association of the 
MBL genes with the Tn402-like transposon 
(GenBank accession number JF810083) was 
investigated by PCR mapping with a com-
bination of primers for the MBL gene [1], 
orf5 [21] and MITEs sequences (MITE_Fw_2: 
5′-GATAACCAATCCATTTATGACA-3′; 
MITE_Rv_2: 5′-TGACTGACCATTAAA- 
GTCTCAA-3′).
The carbapenemase genes location was 
assessed by hybridization of I-CeuI- and 
S1-digested genomic DNA with specific probes 
for the carbapenemases and 16S rRNA genes. 
Plasmid characterization was performed using 
the PCR-based replicon typing scheme for 
A. baumannii plasmids [22].
Transfer of carbapenemase genes was 
attempted by conjugation with rifampicin-
resistant mutant of A. baumannii ATCC 17978 
(kindly provided by Dr Ruth Hall), and by elec-
trotransformation with the plasmid DNA from 
HGSA593 isolate, using Acinetobacter baylyi 
ADP1 (kindly provided by Dr German Bou), 
as the recipient strain. Selection was performed 
on Mueller-Hinton agar plates supplemented 
with imipenem (0.5 mg/l) and rifampicin (100 
mg/l) for conjugation assays and only with imi-
penem (0.5 mg/l) for electrotransformation. 
Presumptive transformants were confirmed by 
searching carbapenemases genes by PCR.
Clonal relatedness for the two isolates was 
assessed by genomic DNA macrorestriction with 
table 1. molecular characterization of A. bereziniae isolates included in this study.
isolate year Source Carbapenemase genes 
(plasmid size, Kb)
Class 1 integron 
content (size, Kb)
antibiotic resistance profile (miC, mg/l)
HGSA93 2008 Water from a newborn 
incubator humidity system
blaIMP-5 (∼310) blaIMP-5 (1.5) IMP (>32); MEM (>32); ATM (32); FEP (>32); 
CAZ (>256); PTZ (>256); K
HGSA593 2012 Blood culture (inpatient with 
chronic renal disease)
blaIMP-5 (∼200), blaOXA-58 
(∼90)
blaIMP-5- blaOXA-4 
(2.5), aacA4 (1.2)
IMP (>32); MEM (>32; 12); ATM (32); FEP (32); 
CAZ (>256); PTZ (>256); K; CN; TOB
β-lactam MICs are presented; resistance transferred by electrotransformation is bold (when only bla
OXA-58
 was transferred) or bold and underlined (when both bla
IMP-5
 and bla
OXA-58
 
were transferred).
ATM: Aztreonam; CAZ: Ceftazidime; CN: Gentamicin; FEP: Cefepime; IMP: Imipenem; K: Kanamycin; MEM: Meropenem; PTZ: Piperacillin-tazobactam; TOB: Tobramycin.
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Figure 1. apa i-, i-Ceu i- and S1-PFGe patterns from A. bereziniae isolates. (a) Apa I-PFGE, lane 
1 HGSA93, lane 2 HGSA593; (B) I-Ceu I- PFGE and respective southern blot, lane 3 HGSA93, lane 4 
HGSA593, lane 5 HGSA93 IMP-5 hybridization, lane 6 HGSA593 IMP-5 hybridization; S1-PFGE and 
respective Southern blot, lane 7 HGSA93, lane 8 HGSA593, lane 9 HGSA93 IMP-5 hybridization, lane 
10 HGSA593 IMP-5 hybridization.
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ApaI followed by pulsed-field gel electrophoresis 
(PFGE).
results & discussion
HGSA93 and HGSA593 isolates belonged to 
A. bereziniae species, according to the rpoB 
partial gene sequencing (with both displaying 
98% nucleotide identity with A. bereziniae type 
strain CIP 70.12T, GenBank accession num-
ber DQ207475.1). The bla
OXA-228
, an intrin-
sic oxacillinase gene from A. bereziniae spe-
cies, was detected by PCR (100% homology 
with bla
OXA-228
 gene described in A. bereziniae 
strain CIP 70.12TGenBank accession number 
JQ422053.1) and presented the same promoter 
sequences (TTCAAT and TGGTAT for the -35 
and -10 sequences, respectively) that have been 
related with its low expression [14,15].
Both isolates presented an unusual antibiotic 
resistance profile that included resistance to all 
tested β-lactams. HGSA93 remained susceptible 
to aminoglycosides (except kanamycin), while 
HGSA593 was only susceptible to amikacin 
(table 1). Blue-carba test revealed the presence 
of carbapenemase activity and the bioassay with 
EDTA strongly suggested the presence of an 
MBL, further identified as IMP-5 in both isolates 
by PCR and sequencing. Search for acquired 
CHDL revealed that HGSA593 also harbored 
bla
OXA-58
, which is a carbapenemase that had 
10.2217/fmb.15.88
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been endemic within this hospital among A. 
baumannii clinical isolates and disappeared 
after 2006 [5]. Sequencing of the bla
IMP-5
-encod-
ing class 1 integron, from HGSA93, revealed 
100% homology with the previously described 
In76 [1] and its nucleotide sequence was depos-
ited in the GenBank database (accession num-
ber KF732850.1). PCR mapping showed that 
this genetic platform was also flanked by MITE 
structures, a fact that might justify bla
IMP-5
 gene 
mobilization [2,3]. Curiously, sequence analysis 
indicated the presence of a weak -35 promoter 
(TTGACA instead of TTGATA) upstream 
bla
IMP-5
 gene [23], contrary to what was expected 
by the observed high carbapenem resistance level 
(table 1). HGSA593 harbored similar genetic 
vicinity for bla
IMP-5
, but the integron content 
included an extra gene cassette (bla
OXA-4
) down-
stream bla
IMP-5
 gene. Moreover, HGSA593 
harbored another class 1 integron carrying an 
aacA4 gene, which might explain its additional 
resistance to aminoglycosides. I-CeuI- and S1 
hybridizations revealed that bla
IMP-5
 gene was 
located in a ∼310 Kb plasmid for HGSA93 and 
in a ∼200 Kb plasmid for HGSA593 (Figure 1) 
and bla
OXA-58
 was located in a ∼90 Kb additional 
plasmid. These plasmids were untypeable using 
the current replicon typing scheme [22], which is 
now commonly reported among non-baumannii 
Acinetobacter species [24]. Conjugation attempts 
were unsuccessful, but plasmids from HGSA593 
were transferred and expressed in A. baylyi 
ADP1, with transformants exhibiting resistance 
to β-lactams, including carbapenems (table 1).
Curiously, ApaI-PFGE assay revealed that A. 
bereziniae isolates were unrelated (Figure 1), sug-
gesting that this species might easily acquire dif-
ferent plasmids and act as reservoir of clinically 
relevant resistance genes.
Conclusion
Our data highlight the ability of non-bau-
mannii Acinetobacter species to acquire rel-
evant resistance genes which could contribute 
for their emergence as nosocomial pathogens. 
Furthermore, cumulative findings suggest that 
different species of Acinetobacter seem to con-
stitute important reservoirs of resistance genes 
outside clinical settings. In this study, although 
the first A. bereziniae isolate was not associated 
with any infection episode, its detection in the 
newborn’s incubator humidity chamber, along 
with the second bloodstream isolate and previ-
ous works on this species, should indicate the 
possibility of ‘environmental’ species emerge 
as etiologic agents of nosocomial infections, 
 particularly within vulnerable populations.
Finally, we believe that further studies focused 
on the local microbial ecology of carbapenemase 
producers are imperative for the full understand-
ing of the observed endemicity of IMP-5 in our 
country and for the effective prevention of its 
dissemination.
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exeCutive summary
 ●  We extended the species reservoir of the ‘exclusively Portuguese’ IMP-5 carbapenemase.
 ●  Environmental Acinetobacter bereziniae isolates could act as reservoirs for blaIMP-5.
 ●  Newborn incubator systems could be a source of carbapenemase producing Acinetobacter spp.
 ●  We confirm the pathogenic potential of carbapenem-resistant A. bereziniae.
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